Oscar Fabregat-Andrés

Dr. Oscar Fabregat-Andrés

orcid

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 August 2014 in European Heart Journal - Cardiovascular Imaging
Verified
Journal Article
Closed access
PDF file
OFOscar Fabregat-Andrés
Oscar Fabregat-Andrés
JEJordi Estornell-Erill
Jordi Estornell-Erill
FRFrancisco Ridocci-Soriano
Francisco Ridocci-Soriano
PGPilar García-González
Pilar García-González
BBBruno Bochard-Villanueva
Bruno Bochard-Villanueva
JCJulio Cortijo
Julio Cortijo
Aims Pulmonary arterial hypertension is known to be related to worse prognosis in patients with heart failure (HF). Quantification of pulmonary vascular resistance (PVR) still requires invasive right heart catheterization. Recent studies have shown an accurate method for non-invasive estimation of PVR by cardiac magnetic resonance (CMR). Our aim was to evaluate the prognostic value of PVR calculated by CMR in patients with congestive HF. Methods and results We calculated PVR by CMR in 132 patients [age 65.6 ± 13.1 years, left ventricular ejection fraction (LVEF) 35.1 ± 16.4%, ischaemic aetiology 40%] recently admitted for decompensated HF and derived to our cardiac imaging unit for diagnosis. Patients with cardiac events (readmission for HF or all-cause death) had higher values of PVR [6.77 ± 1.9 vs. 4.1 ± 1.6 Wood units (Wu), P < 0.001] during follow-up [mean 10.3 (1–31) months]. In multivariable Cox regression analysis, only a PVR ≥5.2 Wu [hazard ratio (HR) 4.27; 95% confidence interval (CI) 1.75–10.42; P < 0.001) and the presence of late gadolinium enhancement (LGE) on CMR (HR 2.24; 95% CI 1.03–4.86; P = 0.04) were independent predictors for adverse events at follow-up. Conclusion Non-invasive estimation of PVR by CMR might be useful for risk stratification of patients with chronic HF, irrespective of aetiology or LVEF.

1 February 2017 in Journal of Cardiovascular Medicine
Verified
Journal Article
Closed access
LFLorenzo Fácila
Lorenzo Fácila
OFOscar Fabregat-Andrés
Oscar Fabregat-Andrés
VBVicente Bertomeu
Vicente Bertomeu
JNJuan P. Navarro
Juan P. Navarro
GMGema Miñana
Gema Miñana
JNJulio Núñez
Julio Núñez
Failure. We sought to evaluate the association between metformin therapy and risk of long-term mortality in patients discharged for decompensated heart failure. Methods We included 835 consecutive type 2 diabetic patients discharged from a cardiology department of a third-level center. All-cause mortality was considered as the primary endpoint and the effect of metformin therapy across the most representative subgroups in heart failure as a secondary endpoint. The association between metformin with all-cause mortality was evaluated by using a Cox regression method. Multivariate analysis included solid prognostic covariates in heart failure. Results At a mean follow-up of 2.4 ± 2 years, mortality rates were significantly lower in patients on treatment with metformin: 1.34 (1.04–1.65) × 10 vs. 2.24 (2.0–2.51) × 10 person-years (P < 0.001). Kaplan–Meier curve revealed a progressive separation of curves already observed during first months of follow-up (log-rank test P < 0.001). In multivariate analysis, this prognostic association remained significant. Conclusion In this cohort of patients with acute heart failure and diabetes, metformin appears to be well tolerated and may be associated with favorable clinical outcomes....

1 April 2016 in Revista Clínica Española
Verified
Journal Article
Closed access
Blanca VelascoBlanca Velasco
Blanca Velasco
OFOscar Fabregat-Andrés
Oscar Fabregat-Andrés
VMV. Montagud
V. Montagud
SMS. Morell
S. Morell
JNJulio Núñez
Julio Núñez
LFL. Fácila
L. Fácila

26 November 2015 in The Anatolian Journal of Cardiology
Verified
Journal Article
Open access
OFOscar Fabregat-Andrés
Oscar Fabregat-Andrés
FPFederico Paredes
Federico Paredes
MPMaria P. Monsalve Pérez
Maria P. Monsalve Pérez
JMJavier Milara
Javier Milara
FRFrancisco Ridocci-Soriano
Francisco Ridocci-Soriano
JCJulio Cortijo
Julio Cortijo
Anadolu Kardiyoloji Dergisi, Anadolu Kardiyol Derg, The Anatolian Journal of Cardiology, Anatol J Cardiol, Cardiology, Cardiovascular Medicine, Surgery, Pediatric Cardiology, Angiology

1 May 2015 in Revista Española de Cardiología (English Edition)
Verified
Journal Article
Closed access
OFOscar Fabregat-Andrés
Oscar Fabregat-Andrés
FRFrancisco Ridocci-Soriano
Francisco Ridocci-Soriano
JEJordi Estornell-Erill
Jordi Estornell-Erill
MCMiguel Corbí-Pascual
Miguel Corbí-Pascual
AVAlfonso Valle-Muñoz
Alfonso Valle-Muñoz
MPMaria P. Monsalve Pérez
Maria P. Monsalve Pérez

1 January 2014 in Cardiology Research
Verified
Journal Article
Open access
PDF file
OFOscar Fabregat-Andrés
Oscar Fabregat-Andrés
Evaluation of a New Shirt-Based Electrocardiogram Device for Cardiac Screening in Soccer Players: Comparative Study With Treadmill Ergospirometry